Search Results 251-260 of 16235 for VEO-IBD

  1. Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders - Mayo Clinic

    Prior history of IBS or inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis), microscopic colitis or celiac disease; Ingestion of ...

  2. Pediatrics Clinical Trials - Medical Professionals

    ... IBD. Study of the Incidence of Electrographic Status Epilepticus and Seizures of PICU Patients at National Children's Hospital in Hanoi, Vietnam. Rochester ...

  3. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  4. Ileoanal anastomosis (J-pouch) surgery - Doctors & Departments - Mayo Clinic

    This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

  5. Medical Research & Education - Mayo Clinic News Network

    Is a hepatitis B immunity check needed for IBD patients? Katie Helwig. May 4, 2023. Leading scientists share advances in Omics- ...

  6. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    ... inflammatory bowel disease (i.e., Crohn's disease, ulcerative colitis, microscopic colitis, and celiac disease). Patient has had an episode of ...

  7. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  8. Gastroenterology and Hepatology - Clinical trials

    ... inflammatory bowel disease and colorectal neoplasia critical to the long-term goal of improving effectiveness of neoplasia detection in patients using non ...

  9. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

  10. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

    Participation eligibility · Subjects with ulcerative colitis (UC), collagenous colitis or indeterminate colitis. · Subject who has had surgical bowel resections ...